NEW YORK, Feb. 7, 2023 /PRNewswire/ -- The Klein Law Firm announces that a class action complaint has been filed…
NEW YORK, Feb. 7, 2023 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against certain…
BENSALEM, Pa., Feb. 6, 2023 /PRNewswire/ -- Law Offices of Howard G. Smith announces that investors with substantial losses have…
NEW YORK, Feb. 5, 2023 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of…
New York, New York--(Newsfile Corp. - February 3, 2023) - WHY: Rosen Law Firm, a global investor rights law firm, reminds…
New York, New York--(Newsfile Corp. - February 2, 2023) - Pomerantz LLP announces that a class action lawsuit has been…
NEW YORK, Feb. 2, 2023 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Fate Therapeutics, Inc. ("Fate" or the…
NEW YORK, Feb. 1, 2023 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class…
Los Angeles, California--(Newsfile Corp. - January 31, 2023) - The Schall Law Firm, a national shareholder rights litigation firm, reminds…
NEW YORK, Jan. 31, 2023 /PRNewswire/ -- The Klein Law Firm announces that a class action complaint has been filed…
NEW YORK, Jan. 30, 2023 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of…
Los Angeles, California--(Newsfile Corp. - January 30, 2023) - The Schall Law Firm, a national shareholder rights litigation firm, reminds…
NEW YORK, Jan. 30, 2023 /PRNewswire/ -- Attention Fate Therapeutics, Inc. ("Fate") (NASDAQ: FATE) shareholders: The Law Offices of Vincent…
SAN DIEGO, Jan. 28, 2023 /PRNewswire/ -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Fate…
NEW YORK, Jan. 27, 2023 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against certain…
New York, New York--(Newsfile Corp. - January 27, 2023) - WHY: Rosen Law Firm, a global investor rights law firm, announces…
Los Angeles, California--(Newsfile Corp. - January 26, 2023) - The Schall Law Firm, a national shareholder rights litigation firm, reminds…
NEW YORK, Jan. 26, 2023 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Fate Therapeutics, Inc. ("Fate" or the…
New York, New York--(Newsfile Corp. - January 25, 2023) - Pomerantz LLP announces that a class action lawsuit has been…
Los Angeles, California--(Newsfile Corp. - January 25, 2023) - The Schall Law Firm, a national shareholder rights litigation firm, reminds…
San Diego, California--(Newsfile Corp. - January 24, 2023) - Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers…
NEW YORK, Jan. 24, 2023 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing…
New York, New York--(Newsfile Corp. - January 24, 2023) - Levi & Korsinsky, LLP notifies investors in Fate Therapeutics, Inc.…
Los Angeles, California--(Newsfile Corp. - January 24, 2023) - The Schall Law Firm, a national shareholder rights litigation firm, reminds…
Los Angeles, California--(Newsfile Corp. - January 23, 2023) - The Schall Law Firm, a national shareholder rights litigation firm, reminds…
Boston, Massachusetts--(Newsfile Corp. - January 23, 2023) - Block & Leviton announces that a class action lawsuit has been filed…
FATE Class Action Investigation has Commenced on Behalf of ShareholdersSan Diego, California--(Newsfile Corp. - January 21, 2023) - Shareholder rights…
Los Angeles, California--(Newsfile Corp. - January 19, 2023) - The Schall Law Firm, a national shareholder rights litigation firm, announces…
Boston, Massachusetts--(Newsfile Corp. - January 17, 2023) - Block & Leviton is investigating Fate Therapeutics, Inc. (NASDAQ: FATE) for…
Mendlein, John - Aufsichtsrat - Tag der Transaktion: 2023-01-13...…
Mendlein, John - Aufsichtsrat - Tag der Transaktion: 2023-01-11...…
Los Angeles, California--(Newsfile Corp. - January 12, 2023) - The Schall Law Firm, a national shareholder rights litigation firm, announces…
Chu, Yu-Waye - Vorstand - Tag der Transaktion: 2023-01-10...…
Plavsic, Mark - Vorstand - Tag der Transaktion: 2023-01-10...…
Boston, Massachusetts--(Newsfile Corp. - January 11, 2023) - Block & Leviton is investigating Fate Therapeutics, Inc. (NASDAQ: FATE) for…
Los Angeles, California--(Newsfile Corp. - January 11, 2023) - The Schall Law Firm, a national shareholder rights litigation firm, announces…
Los Angeles, California--(Newsfile Corp. - January 10, 2023) - The Schall Law Firm, a national shareholder rights litigation firm, announces…
Fate Therapeutics's (NASDAQ:FATE) short percent of float has fallen 4.62% since its last report. The company recently reported that it…
Boston, Massachusetts--(Newsfile Corp. - January 6, 2023) - Block & Leviton is investigating Fate Therapeutics, Inc. (NASDAQ: FATE) for potential…
Shares of Fate Therapeutics Inc. FATE plunged 56.8% in premarket trading, putting them on track for a record one-day selloff,…
Stocks to Watch: World Wrestling Ent., Spruce Bios, CytomX Therapeutics, Graphite Bio, Fate Therapeutics...…
Fate Therapeutics Shares Plunge 52% On Terminated Collaboration with Janssen, Layoff Plans...…
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Ended 2022 with Approximately $475 Million in Cash, Cash Equivalents & Receivables; 3-year Operational Runway Provided through Pipeline Prioritization and…
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Fate Therapeutics (FATE) saw its shares surge in the last session with trading volume being higher than average. The latest…
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Presentation shows the therapeutic potential of combining iPSC-derived CAR NK cells and NK cell engagers to overcome the clinical heterogeneity…
Interim Phase 1 Data of FT576 BCMA-targeted Product Candidate Show Clinical Activity in Initial Single-dose Escalation Cohorts as Monotherapy and…
FT819 Off-the-Shelf CAR T-cell Product Candidate Derived from Clonal Engineered Master iPSC Line with Novel CD19-specific 1XX CAR Integrated into…